Erratum: Clinical features and prognosis of resectable pulmonary primary invasive mucinous adenocarcinoma (Transl Lung Cancer Res (2022) 11 (420-431) DOI: 10.21037/tlcr-22-190)
Publication
, Journal Article
Xu, X; Shen, W; Wang, D; Li, N; Huang, Z; Sheng, J; Rucker, AJ; Mao, W; Xu, H; Cheng, G
Published in: Translational Lung Cancer Research
December 1, 2022
This article (1) titled "Clinical features and prognosis of resectable pulmonary primary invasive mucinous adenocarcinoma" (doi: 10.21037/tlcr-22-190), unfortunately contains an error in the primary affiliation for Haimiao Xu and Guoping Cheng. The current affiliation 8 should be the primary affiliation for Haimiao Xu and Guoping Cheng. Therefore, a superscript "*" should be added to the 8th affiliation for explanation.
Duke Scholars
Published In
Translational Lung Cancer Research
DOI
EISSN
2226-4477
ISSN
2218-6751
Publication Date
December 1, 2022
Volume
11
Issue
12
Start / End Page
2608 / 2609
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Xu, X., Shen, W., Wang, D., Li, N., Huang, Z., Sheng, J., … Cheng, G. (2022). Erratum: Clinical features and prognosis of resectable pulmonary primary invasive mucinous adenocarcinoma (Transl Lung Cancer Res (2022) 11 (420-431) DOI: 10.21037/tlcr-22-190). Translational Lung Cancer Research, 11(12), 2608–2609. https://doi.org/10.21037/tlcr-2022-6
Xu, X., W. Shen, D. Wang, N. Li, Z. Huang, J. Sheng, A. J. Rucker, W. Mao, H. Xu, and G. Cheng. “Erratum: Clinical features and prognosis of resectable pulmonary primary invasive mucinous adenocarcinoma (Transl Lung Cancer Res (2022) 11 (420-431) DOI: 10.21037/tlcr-22-190).” Translational Lung Cancer Research 11, no. 12 (December 1, 2022): 2608–9. https://doi.org/10.21037/tlcr-2022-6.
Xu X, Shen W, Wang D, Li N, Huang Z, Sheng J, et al. Erratum: Clinical features and prognosis of resectable pulmonary primary invasive mucinous adenocarcinoma (Transl Lung Cancer Res (2022) 11 (420-431) DOI: 10.21037/tlcr-22-190). Translational Lung Cancer Research. 2022 Dec 1;11(12):2608–9.
Xu, X., et al. “Erratum: Clinical features and prognosis of resectable pulmonary primary invasive mucinous adenocarcinoma (Transl Lung Cancer Res (2022) 11 (420-431) DOI: 10.21037/tlcr-22-190).” Translational Lung Cancer Research, vol. 11, no. 12, Dec. 2022, pp. 2608–09. Scopus, doi:10.21037/tlcr-2022-6.
Xu X, Shen W, Wang D, Li N, Huang Z, Sheng J, Rucker AJ, Mao W, Xu H, Cheng G. Erratum: Clinical features and prognosis of resectable pulmonary primary invasive mucinous adenocarcinoma (Transl Lung Cancer Res (2022) 11 (420-431) DOI: 10.21037/tlcr-22-190). Translational Lung Cancer Research. 2022 Dec 1;11(12):2608–2609.
Published In
Translational Lung Cancer Research
DOI
EISSN
2226-4477
ISSN
2218-6751
Publication Date
December 1, 2022
Volume
11
Issue
12
Start / End Page
2608 / 2609
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences